Search Within

Thoracic Oncology

Formats
  1. Meeting Abstract (1709)
  2. Journal Article (1439)
  3. Review (82)
  4. Editorial (58)
  5. Book Section (35)
  6. Guidelines (25)
  7. Conference Paper (21)
  8. Correspondence (10)
  9. Research Letter (7)
  10. Miscellaneous (6)
  11. Book Whole (2)
Groups
  1. Department of Medicine (3394)
  2. Solid Tumor Oncology Division (3394)
  3. GSK Faculty (1071)
  4. Department of Pathology and Laboratory Medicine (809)
  5. Center for Molecular Imaging and Biotechnology (CMIB) (662)
  6. Human Oncology and Pathogenesis Program (635)

More Groups

People
  1. Mark Kris (872)
  2. Alexander Drilon (637)
  3. Gregory Riely (605)
  4. Charles Rudin (495)
  5. Marc Ladanyi (418)
  6. Matthew Hellmann (412)

More People

Years
  1. 2025 (114)
  2. 2024 (271)
  3. 2023 (273)
  4. 2022 (337)
  5. 2021 (337)
  6. 2020 (258)

More Years

Publications
  1. Journal of Clinical Oncology (703)
  2. Journal of Thoracic Oncology (517)
  3. Annals of Oncology (278)
  4. Clinical Cancer Research (158)
  5. Cancer Research (128)
  6. International Journal of Radiation Oncology, Biology, Physics (89)

More Publications

Publishers
  1. American Society of Clinical Oncology (782)
  2. Elsevier Inc. (738)
  3. American Association for Cancer Research (386)
  4. Oxford University Press (352)
  5. Nature Publishing Group (156)
  6. Elsevier Science, Inc. (79)

More Publishers

Results (3394)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Final results of a phase I trial of stereotactic body radiotherapy for larger (>3cm) inoperable non-small cell lung cancer
    Meeting Abstract

    Zhang, S. Y.; Chaft, J.; Wu, A. J.; Cuaron, J. J.; Gelblum, D.; von Reibnitz, D.; Gelb, E.; Ng, K.; Yorke, E. D.; Rimner, A.
    International Journal of Radiation Oncology, Biology, Physics (2020)

    Fulltext@MSK | Save
  • One-year disease outcomes in stage III non-small cell lung cancers treated with trimodality therapy vs concurrent chemoradiation and durvalumab
    Meeting Abstract

    Shaverdian, N.; Shepherd, A. F.; Offin, M.; Lobaugh, S.; Zhang, Z.; Simone, C. B. 2nd; Gelblum, D.; Wu, A. J.; Kris, M. G.; Rudin, C. M.; more...
    International Journal of Radiation Oncology, Biology, Physics (2020)

    Fulltext@MSK | Save
  • Exploring associations between immune parameters and radiation pneumonitis in locally advanced non-small cell lung cancer after chemoradiation and durvalumab
    Meeting Abstract

    Thor, M.; Shaverdian, N.; Shepherd, A. F.; Offin, M.; Jackson, A.; Wu, A. J.; Gelblum, D.; Yorke, E. D.; Simone, C. B. 2nd; Gomez, D. R.; more...
    International Journal of Radiation Oncology, Biology, Physics (2020)

    Fulltext@MSK | Save
  • A pre-treatment PET And CT-derived model for progression-free survival in early stage non-small cell lung cancer
    Meeting Abstract

    Thor, M.; Fitzgerald, K. J.; Apte, A.; Oh, J. H.; Iyer, A.; Nadeem, S.; Choi, W.; Yorke, E. D.; Chaft, J.; Wu, A. J.; more...
    International Journal of Radiation Oncology, Biology, Physics (2020)

    Fulltext@MSK | Save
  • Inter-tumoral heterogeneity of progressive disease in melanoma patients treated with pembrolizumab
    Meeting Abstract

    Topp, B.; Kumar, R.; Mayawala, K.; de Alwis, D.; Hellmann, M. D.; Snyder, A.
    Cancer Research (2020)

    Fulltext@MSK | Save
  • KRYSTAL-1: Activity and safety of adagrasib (MRTX849) in advanced/ metastatic non-small-cell lung cancer (NSCLC) harboring KRAS G12C mutation
    Meeting Abstract

    Jänne, P. A.; Rybkin, I. I.; Spira, A. I.; Riely, G. J.; Papadopoulos, K. P.; Sabari, J. K.; Johnson, M. L.; Heist, R. S.; Bazhenova, L.; Barve, M.; more...
    European Journal of Cancer (2020)

    Fulltext@MSK | Save
  • Concurrent targeting of potential cancer stem cells regulating pathways sensitizes lung adenocarcinoma to standard chemotherapy
    Journal Article

    Shibata, M.; Ooki, A.; Inokawa, Y.; Sadhukhan, P.; Ugurlu, M. T.; Izumchenko, E.; Munari, E.; Bogina, G.; Rudin, C. M.; Gabrielson, E.; more...
    Molecular Cancer Therapeutics (2020)

    Fulltext@MSK | Save
  • Molecular engineering of ultrasmall silica nanoparticle-drug conjugates as lung cancer therapeutics
    Journal Article

    Madajewski, B.; Chen, F.; Yoo, B.; Turker, M. Z.; Ma, K.; Zhang, L.; Chen, P. M.; Juthani, R.; Aragon-Sanabria, V.; Gonen, M.; more...
    Clinical Cancer Research (2020)

    Fulltext@MSK | Save
  • Supporting clinical decision-making during the SARS-CoV-2 pandemic through a global research commitment: The TERAVOLT experience
    Editorial

    Trama, A.; Proto, C.; Whisenant, J. G.; Torri, V.; Cortellini, A.; Michielin, O.; Barlesi, F.; Dingemans, A. M. C.; Van Meerbeeck, J.; Pancaldi, V.; more...
    Cancer Cell (2020)

    Fulltext@MSK | Save
  • Round Robin evaluation of MET protein expression in lung adenocarcinomas improves interobserver concordance
    Journal Article

    Boyle, T. A.; Khalil, F. K.; Mino-Kenudson, M.; Sica, G. L.; Moreira, A. L.; Sholl, L. M.; Knight, M. Z.; Zhang, L.; Saller, J.; Varella-Garcia, M.; more...
    Applied Immunohistochemistry & Molecular Morphology (2020)

    Fulltext@MSK | Save